The markets have been a bit shaky between oil prices evaporating and shareholders looking ahead to testimony from Janet Yellen. On Monday morning as wary shareholders...
It appears that after January’s volatile open, the biotech sector is back in the spotlight and could be set for a rally in February. The allure...
The markets have been choppy to say the least amid oil price volatility and investors looking ahead to testimony from Janet Yellen. The Dow Jones industrial...
Biotechnology stocks have had their fair share of bumps and bruises after heavy concern surrounding pricing was brought up by several presidential candidates during the first...
Over the past few months, the biotech sector saw a large sell-off ignited by pricing worries. Democratic Presidential candidate Hillary Clinton’s “price gouging” tweet she posted...